In a study published in the highly respected journal “Biological Psychiatry”, researchers from the MedUni Vienna have now discovered a potential biological mechanism behind this relationship.
As they grow older and as their sex hormone output falls, men suffer more commonly from depression and some studies have already demonstrated a positive effect of testosterone supplementation on the moods of the test subjects. Now, the study led by Rupert Lanzenberger from the University Department of Psychiatry and Psychotherapy has demonstrated for the first time worldwide that testosterone increases the number of serotonin transporters (proteins) in the human brain. These proteins regulate the concentration of serotonin and are also the target for antidepressants.
Serotonin transporters increased after just four weeks of hormone therapy
As a model for investigating the effect of testosterone, the researchers from the MedUni Vienna chose hormone therapy given to transsexuals. Says primary author Georg Kranz: “Transsexuals are people who feel that they are living in the wrong body and who therefore want high doses of opposite gender hormone therapy to adapt their appearance to that of the other gender. Genetic women are given testosterone, while genetic men are given oestradiol and medications to suppress testosterone production.”
Using the imaging method of positron emission tomography (PET), the scientists together with Wolfgang Wadsak and Markus Mitterhauser from the Clinical Department of Nuclear Medicine and Ulrike Kaufmann from the University Department of Gynaecology have demonstrated that serotonin transporter levels in the brain are significantly higher after just four weeks of hormone therapy with testosterone and that they rise further if therapy continues. Moreover, a close relationship has also been demonstrated between testosterone levels in the blood and the concentration of serotonin transporters.
“The study has shown that testosterone increases the potential binding sites for commonly prescribed antidepressants such as SSRIs in the brain and therefore provides major insights into how sex hormones affect the human brain and gender differences in psychiatric illnesses,” says Siegfried Kasper, Head of the University Department of Psychiatry and Psychotherapy at the MedUni Vienna.
Translational cooperation project at the MedUni Vienna
The study, sponsored by the FWF science fund and the anniversary fund of the Austrian National Bank, was carried out as part of a cooperation project between three departments at the MedUni Vienna. Researchers from the University Department of Psychiatry and Psychotherapy (led by Siegfried Kasper), the University Department of Radiology and Nuclear Medicine (cooperation partners: Wolfgang Wadsak and Markus Mitterhauser) and the University Department of Gynaecology at the MedUni Vienna (cooperation partner: Ulrike Kaufmann) were involved.
Service: Journal “Biological Psychiatry”
“High-dose testosterone treatment increases serotonin transporter binding in transgender people.” Kranz GS, Wadsak W, Kaufmann U, Savli M, Baldinger P, Gryglewski G, Haeusler D, Spies M, Mitterhauser M, Kasper S, Lanzenberger R. Biological Psychiatry 2014 Sep 23 [IF: 9.472].
Five research clusters at the MedUni Vienna
A total of five research clusters have been set up at the MedUni Vienna in which the MedUni Vienna is increasing its focus in the fields of fundamental and clinical research. The research clusters include medical imaging, cancer research / oncology, cardiovascular medicine, medical neurosciences and immunology. The present work falls in terms of its content within the remit of medical neurosciences.